Free Trial

Hims & Hers Health Q2 2023 Earnings Report

Hims & Hers Health logo
$29.70 +1.86 (+6.66%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Hims & Hers Health EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.06
Beat/Miss
Beat by +$0.03
One Year Ago EPS
-$0.10

Hims & Hers Health Revenue Results

Actual Revenue
$207.91 million
Expected Revenue
$204.95 million
Beat/Miss
Beat by +$2.96 million
YoY Revenue Growth
+83.10%

Hims & Hers Health Announcement Details

Quarter
Q2 2023
Time
After Market Closes

Conference Call Resources

Hims & Hers Health Earnings Headlines

Hims & Hers: Ready To Outperform Further
WARNING: “Buffett Indicator” flashing for first time in 50 years
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.
Hims & Hers Health (NYSE:HIMS) Sees Large Volume Increase - What's Next?
Hims & Hers falls -6.5%
See More Hims & Hers Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hims & Hers Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hims & Hers Health and other key companies, straight to your email.

About Hims & Hers Health

Hims & Hers Health (NYSE:HIMS) operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

View Hims & Hers Health Profile

More Earnings Resources from MarketBeat